Lung cancer becomes one of the diseases with a high mortality rate. The identification of lung nodules as a representation of lung cancer becomes a very important part. One method of identifying lung ...

Cite this: Kaposi's Sarcoma in the Pediatric Population: The Critical Need for a Tissue Diagnosis - Medscape - May 01, 2009. Abstract and Case Report Discussion ...

BACKGROUND Low attenuation areas (LAA) on computed tomographic (CT) scans have been shown to represent emphysematous changes in patients with chronic obstructive pulmonary disease (COPD). However, the ...

Accurate and fast extraction of lung volumes from computed tomography (CT) scans remains in a great demand in the clinical environment because the available methods fail to provide a generic solution ...

Results: There were statistical differences in all quantitative parameters of lung nodules between the inspiratory CT and the expiratory CT (all P<0.05). The change ratio of long axis diameter of ...

The elusive and enigmatic origin of AIDS-associated Kaposi's sarcoma (AIDS-KS) makes it a complex tumor and therefore difficult to treat. Here we demonstrate that AIDS-KS cells express surface ...

A downside to CT screening for lung cancer is that the test can have false-positive findings that lead to unnecessary medical procedures. For instance, your doctor might spot a nodule that looks ...

positive topline efficacy results from its completed U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (“STS lung mets”) (MB-107).

Background Prior work suggests different interstitial lung diseases (ILDs) that share the radiological usual interstitial pneumonia (UIP) pattern have an overall worse prognosis. However, ...

Access the on-demand webcast here HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company ...

Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company’s lead program ...

Metastatic disease occurring in 30% to 35% of patients. 5 Undifferentiated pleomorphic sarcoma most commonly metastasizes to the lungs (90% of cases) and less commonly to the lymph nodes, bone, or ...